Patent · US Active

Treatment of vasculitis

US8545843B2 · kind B2 · utility

49Cited by
76References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 20, 2010
Grant dateOct 1, 2013
Priority date—
Expiry dateSep 20, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S424/81
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.